Robuta

TBS improved similarly with cyclic and standard treatment regimens of TPTD and denosumab over 36 months, however possible differences may have been masked by...

Each year in the United States, 53 million people have low bone mass or osteoporosis [ 1 ], resulting in approximately 2 million osteoporosis-related